Intellectual Property

  • Report


    Emerging Technology and Risk Analysis: Additive Manufacturing

    Additive manufacturing is increasingly important for licit and illicit uses. This report focuses on illicit commercial use, particularly counterfeiting, because of its potentially significant effects on economic prosperity and national security.

    Feb 15, 2024

  • AI on advanced central processing unit with a judge's gavel, photo by Dragon Claws/Getty Images


    The Case for and Against AI Watermarking

    The hype around the concept of AI-output watermarking may be masking very real system challenges. And failure to address watermarking as a systems problem is likely to result in solutions that risk working against the security and trust they seek to instill.

    Jan 17, 2024

  • People stand in line in front of Huawei's new flagship store, as it officially opens in Shanghai, China, June 24, 2020, photo by Aly Song/Reuters


    Business Community Support for U.S. Policies Toward China

    Policies implemented by the Trump administration were designed to confront China over its problematic behaviors, such as theft of technology and intellectual property. U.S. businesses agreed with the policies, but questioned some of the tactics used. How can Washington address corporate concerns and still compete against China?

    May 16, 2022

  • 17th Special Operations Squadron conducts full-force training, photo by Senior Airman Peter Reft/U.S. Air Force


    Managing Intellectual Property Relevant to Operating and Sustaining Major U.S. Air Force Weapon Systems

    Expanded reliance on original equipment manufacturers have led the U.S. Air Force to give less priority to acquiring appropriate intellectual property. What organizational change should the Air Force consider to better acquire and use intellectual property?

    Sep 14, 2021

  • RAND Weekly Recap


    Vaccine Hesitancy, Working from Home, Arctic Diplomacy: RAND Weekly Recap

    This weekly recap focuses on vaccine hesitancy as a symptom of ‘Truth Decay,’ how to make remote work beneficial for all, U.S. Arctic diplomacy, and more.

    May 21, 2021

  • Vials with Pfizer-BioNTech and Moderna COVID-19 vaccine labels, March 19, 2021, photo by Dado Ruvic/Reuters


    Vaccine Patents Debate Risks Becoming a Sideshow

    As COVID-19 cases continue to surge around the world, the debate is raging over whether patents on existing vaccines should be waived. But the global community could view patent waivers as just one of many available tools for speeding up vaccine delivery worldwide.

    May 17, 2021

  • A scientist working late in a laboratory, photo by SolStock/Getty Images


    Scientific Research Integrity Demands Transparency—the Law Should Require It Too

    China pays U.S. scientists for their innovations in exchange for money and access to research laboratories and speaking and publication opportunities. They require the researchers to keep these agreements secret from their employers or the U.S. government. Perhaps it is time to codify scientific transparency into law.

    Apr 12, 2021

  • A laboratory technician working on research for a vaccine against COVID-19 in Bern, Switzerland, April 22, 2020, photo by Arnd Wiegmann/Reuters


    Needed: A Blueprint for a Post-Vaccine World

    When a COVID-19 vaccine is developed, many in rich countries may be able to afford it while the poor and uninsured may not. The time to plan for equitable access, financing, intellectual property rights, and global production is now.

    May 11, 2020

  • Report

    The Role of Intellectual Property in U.S. Homeland Security

    Researchers assessed intellectual property (IP) support at the U.S. Department of Homeland Security (DHS) and its components and found underused opportunities but also issues that expose programs to substantial risk.

    Sep 19, 2019

  • Israeli Prime Minister Benjamin Netanyahu and Chinese President Xi Jinping shake hands ahead of their talks at Diaoyutai State Guesthouse in Beijing, China, March 21, 2017, photo by Etienne Oliveau/Reuters/Pool


    How Has the Israel-China Relationship Evolved?

    Since the early 2000s, relations between China and Israel have expanded in areas like diplomacy, trade, investment, construction, educational partnerships, scientific cooperation, and tourism. What challenges does the relationship pose for Israel and the United States?

    Mar 21, 2019

  • Dissertation


    Patenting and Innovation in China: Incentives, Policy, and Outcomes

    Explores the drivers behind China's patent boom, the impact of patenting-promoting policies, and the innovative outcomes of Chinese firms.

    Mar 6, 2015

  • Members of the the Group of the Greens/European Free Alliance hold posters during a voting session on the Anti-Counterfeiting Trade Agreement (ACTA) at the European Parliament in Strasbourg, July 4, 2012


    ACTA Revisited? TTIP and Data Privacy

    The EU has embarked on negotiations with the U.S. on the TTIP, which shares some of ACTA's goals. This time, though, the European Commission is seeking to make the talks more transparent by publishing a series of position papers on key issues very early on in the process. This is a step in the right direction toward an agreement that will have economic benefits for a net-exporting region of intellectual property such as the EU.

    Nov 26, 2014

  • two scientists studying various colored substances in a laboratory


    A New Model for Open Innovation: The Structural Genomics Consortium

    Open innovation is often suggested as a solution to enhance productivity in under-performing areas of research. Now, the strengths and weaknesses of a new open innovation model in drug discovery have been evaluated.

    Mar 25, 2014

  • News Release

    News Release

    The Structural Genomics Consortium, an Innovative Open-Access, Public–Private Partnership, Is a Viable Model for Drug ...

    The Structural Genomics Consortium is a viable model for drug discovery that appeals to investors, not least for advantages in efficiency over current models of public or commercial health research.

    Mar 10, 2014

  • DNA molecule


    Structural Genomics Consortium Offers Knowledge Platform for Drug Discovery

    An independent evaluation of the Structural Genomics Consortium (SGC) examined the strengths and weaknesses of its efforts to support drug discovery efforts through a unique, open access model of public-private collaboration.

    Mar 10, 2014

  • Report


    The Structural Genomics Consortium: A knowledge platform for drug discovery: A summary

    This report summarises the results of an independent evaluation of the Structural Genomics Consortium, an open access model of public-private collaboration, conducted by RAND Europe with the Institute on Governance.

    Mar 10, 2014

  • Commentary

    The Costs of Counterfeiting

    Efforts to come to grips with intellectual property rights aren't dying down after the European Parliament voted down the Anti-Counterfeiting Trade Agreement (ACTA) last summer. Indeed, the need for evidence of the scale and impact of counterfeiting has only become more pressing. A RAND Europe report points to a potential solution and has already been dubbed

    Nov 28, 2012

  • News Release

    News Release

    New Method for Estimating Costs of Counterfeiting Presented

    A new method for estimating the costs of counterfeiting was published today by RAND Europe. The approach uses market data to estimate the effects of intellectual property rights infringements, such as counterfeit products, on sales of legitimate goods.

    Sep 27, 2012

  • Report


    A New Approach to Measure Intellectual Property Rights Infringements

    Globalization, integrated markets, and the Internet economy have contributed to the rise in IPR infringements. RAND developed a methodology based on economic theory to contribute to quantifying the scope, scale, and impact of IPR infringements, such as counterfeiting, unauthorized downloads, and piracy.

    Sep 27, 2012

  • Report

    Intellectual Property and Developing Countries: A review of the literature

    This report examines the impact of intellectual property rights in developing countries, in the context of the World Trade Organization's Agreement on Trade-Related Intellectual Property Rights (TRIPS) and the development of TRIPS-plus standards.

    Feb 22, 2010